Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0030567 (Parkinson's disease)
 63,064 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The XVIII World Federation of Neurology (WFN) World Congress on Parkinson's Disease and Related Disorders, held in Miami, FL, USA, included topics covering new therapeutic developments in this field. This conference report highlights selected presentations on the pathophysiology and treatment of these diseases, including the design of neuroprotective compounds, protein inhibition in the absence of catechol-O-methyltransferase (COMT), evaluating the striatal distribution of COMT, clinical results for PYM-50028 (Phytopharm plc) and ProSavin, and research into the use of stem cell treatments for Parkinson's disease.
 ...
PMID:Parkinson's disease and related disorders--XVIII WFN World Congress. 2012 58

The 14th International Congress of Parkinson's Disease and Movement Disorders, held in Buenos Aires, included topics covering new therapeutic developments in the field of Parkinson's disease and other movement disorders. This conference report highlights selected presentations on drug treatments for movement disorders, including safinamide (Merck Serono SA), PYM-50028 (Phytopharm plc), droxidopa, pardoprunox (Abbott Laboratories); treatment considerations for dystonia; exploiting existing drugs for new indications; and using genetics to assess drug therapy responses.
 ...
PMID:The Movement Disorder Society--14th International Congress of Parkinson's Disease and Movement Disorders. 2072 24